Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henrike Veninga

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Molecular Immunology|August 24, 2007
The inhibitory CD200R is differentially expressed on human and mouse T and B lymphocytesEva S K Rijkers, Talitha de Ruiter, Ajoeb Baridi, et al.
European Journal of Haematology|September 7, 2007
Ligation of CD200R by CD200 is not required for normal murine myelopoiesisEva S K Rijkers, Talitha de Ruiter, Miranda Buitenhuis, et al.
Advances in Experimental Medicine and Biology|May 31, 2011
CD97 in leukocyte traffickingJörg Hamann, Henrike Veninga, Dorien M de Groot, et al.
European Journal of Immunology|December 10, 2014
Antigen targeting reveals splenic CD169+ macrophages as promoters of germinal center B-cell responsesHenrike Veninga, Ellen G F Borg, Kyle Vreeman, et al.
Frontiers in Immunology|September 22, 2018
Comparison of Protein and Peptide Targeting for the Development of a CD169-Based Vaccination Strategy Against MelanomaDieke van Dinther, Henrike Veninga, Mirjam Revet, et al.
Journal of Leukocyte Biology|December 21, 2010
CD97 antibody depletes granulocytes in mice under conditions of acute inflammation via a Fc receptor-dependent mechanismHenrike Veninga, Dorien M de Groot, Natalie McCloskey, et al.
Immunology|June 3, 2014
The identification and developmental requirements of colonic CD169⁺ macrophagesIda H Hiemstra, Marieke R Beijer, Henrike Veninga, et al.
Biomaterials|March 15, 2005
The modulation of angiogenesis in the foreign body response by the poxviral protein M-T7Jasper M Boomker, Daniël T Luttikhuizen, Henrike Veninga, et al.
Cancers|February 16, 2019
Activation of CD8⁺ T Cell Responses after Melanoma Antigen Targeting to CD169⁺ Antigen Presenting Cells in Mice and HumansDieke van Dinther, Miguel Lopez Venegas, Henrike Veninga, et al.
Frontiers in Immunology|February 24, 2018
Dendritic Cell Migration to Skin-Draining Lymph Nodes Is Controlled by Dermatan Sulfate and Determines Adaptive Immunity MagnitudeReza Nadafi, Jasper J Koning, Henrike Veninga, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Molecular Immunology|August 24, 2007
The inhibitory CD200R is differentially expressed on human and mouse T and B lymphocytesEva S K Rijkers, Talitha de Ruiter, Ajoeb Baridi, et al.
European Journal of Haematology|September 7, 2007
Ligation of CD200R by CD200 is not required for normal murine myelopoiesisEva S K Rijkers, Talitha de Ruiter, Miranda Buitenhuis, et al.
Advances in Experimental Medicine and Biology|May 31, 2011
CD97 in leukocyte traffickingJörg Hamann, Henrike Veninga, Dorien M de Groot, et al.
European Journal of Immunology|December 10, 2014
Antigen targeting reveals splenic CD169+ macrophages as promoters of germinal center B-cell responsesHenrike Veninga, Ellen G F Borg, Kyle Vreeman, et al.
Frontiers in Immunology|September 22, 2018
Comparison of Protein and Peptide Targeting for the Development of a CD169-Based Vaccination Strategy Against MelanomaDieke van Dinther, Henrike Veninga, Mirjam Revet, et al.
Journal of Leukocyte Biology|December 21, 2010
CD97 antibody depletes granulocytes in mice under conditions of acute inflammation via a Fc receptor-dependent mechanismHenrike Veninga, Dorien M de Groot, Natalie McCloskey, et al.
Immunology|June 3, 2014
The identification and developmental requirements of colonic CD169⁺ macrophagesIda H Hiemstra, Marieke R Beijer, Henrike Veninga, et al.
Biomaterials|March 15, 2005
The modulation of angiogenesis in the foreign body response by the poxviral protein M-T7Jasper M Boomker, Daniël T Luttikhuizen, Henrike Veninga, et al.
Cancers|February 16, 2019
Activation of CD8⁺ T Cell Responses after Melanoma Antigen Targeting to CD169⁺ Antigen Presenting Cells in Mice and HumansDieke van Dinther, Miguel Lopez Venegas, Henrike Veninga, et al.
Frontiers in Immunology|February 24, 2018
Dendritic Cell Migration to Skin-Draining Lymph Nodes Is Controlled by Dermatan Sulfate and Determines Adaptive Immunity MagnitudeReza Nadafi, Jasper J Koning, Henrike Veninga, et al.
Pageof 2